e-learning
resources
London 2016
Sunday, 04.09.2016
Molecular pathways of smoking-induced diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of CYP2A6 and CYP2A13 genes using new generation sequencing method in smokers and non-smokers.
Mehmet Atilla Uysal (Istanbul, Turkey), Sacide Pehlivan, Mehmet Atilla Uysal, Tülin Çagatay, Cigdem Keklik Cinar, Feyza Erkan, Ulgen Sever, Zuleyha Bingol, Mustafa Pehlivan, Yedikule Smoking Cessation Study Group, Sadrettin Pençe
Source:
International Congress 2016 – Molecular pathways of smoking-induced diseases
Session:
Molecular pathways of smoking-induced diseases
Session type:
Oral Presentation
Number:
1485
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mehmet Atilla Uysal (Istanbul, Turkey), Sacide Pehlivan, Mehmet Atilla Uysal, Tülin Çagatay, Cigdem Keklik Cinar, Feyza Erkan, Ulgen Sever, Zuleyha Bingol, Mustafa Pehlivan, Yedikule Smoking Cessation Study Group, Sadrettin Pençe. Analysis of CYP2A6 and CYP2A13 genes using new generation sequencing method in smokers and non-smokers.. Eur Respir J 2016; 48: Suppl. 60, 1485
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Asbestosis
Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine
Related content which might interest you:
Genetic differences in COPD secondary to wood smoke and tobacco smoking
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013
Influence of allele variants of CYP2A6 and NAT2 genes on features of phenotype of tobacco smoker
Source: Eur Respir J 2004; 24: Suppl. 48, 503s
Year: 2004
Metabolomic profiles in lung cancer subjects and healthy controls. Influence of smoking tobacco exposure
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Gene polymorphisms of p53 at codon 72 and MDM2 SNP309 are associated with lung cancer risk and emphysematous changes in smokers
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Novel genes associated with the level of FEV1 in never-smokers in the context of occupational exposure
Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD
Year: 2015
Interaction between interleukin 6 gene polymorphisms and second-hand smoke exposure on adult-onset asthma
Source: International Congress 2014 – Genes and environment in asthma and COPD
Year: 2014
Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms
Source: Eur Respir J 2006; 27: 289-292
Year: 2006
Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
The CYP2A6 gene polymorphism in male Bataknese smoker lung cancer patients and its association with nicotine dependence
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Genetic variant of the nicotinic receptor gene and the long term prognosis of smokers
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013
Genetic variants in NRXN1, CHRNA3, CHRNA5 and CHRNB4 are associated with smoking and increased consumption of cigarettes per day in a Mexican mestizo population
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Association between candidate gene polymorphisms and asthma severity in adults. A Bayesian analysis
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016
Polimorphism in the site rs12914008 of the CHRNB4 subunit gene may be associated with the fast transition from initial smoking to nicotine dependence (ND)
Source: Annual Congress 2013 –World tour of tobacco epidemiology
Year: 2013
Transposable element LINE1 is activated after exposure to cigarette smoke in primary human lung fibroblasts.
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Genes, the environment and the lung
Source: Annual Congress 2006 - Genes, environment and the lung
Year: 2006
Altered circulating exosomal RNA profiles detected by next-generation sequencing in patients with severe asthma
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Interaction between genes and smoking on lung function: a genome-wide approach
Source: International Congress 2015 – PG15 Gene-environment interactions in lung disease
Year: 2015
meQTL analysis of asthma GWAS loci and DNA methylation
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016
Gene-by-occupational exposure interaction and gene expression analysis on the level of FEV
1
Source: International Congress 2014 – Genes and environment in asthma and COPD
Year: 2014
LSC - 2020 - Transcriptome signatures of tobacco carcinogens hint the alteration of TAF6 as a specific feature in smokers lung cancer
Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept